Opportunity ID: 348286
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | HT9425-23-NFRP-NFRA-LA |
Funding Opportunity Title: | DoD Neurofibromatosis Research Academy-Leadership Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 1 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | May 22, 2023 |
Last Updated Date: | Aug 10, 2023 |
Original Closing Date for Applications: | Aug 25, 2023 |
Current Closing Date for Applications: | Oct 05, 2023 |
Archive Date: | Nov 04, 2023 |
Estimated Total Program Funding: | $2,080,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: |
All applications for this award must address at least the strategic goal “Increase research capacity” as stated in Section II.A.1 above. The NFRP Neurofibromatosis Research Academy (NFRA) will bring together established investigators (Director and Deputy Director) and early-career independent investigators (Scholars) to develop successful, highly productive neurofibromatosis researchers that will conduct research with the aim of lessening the clinical impact of NF1, NF2, and Schwannomatosis. The NFRA is a unique, multi-institutional interactive virtual research academy focused on supporting innovative high-impact research in a collaborative research and career development environment. The NFRA will provide a framework of intensive monitoring and iterative guidance with proposed research, national networking, collaborations, and a peer group for Scholars. The NFRA is a platform that consists of Scholars and their Career Guides (mentors) from different institutions, and an Academy Director and Deputy Director (see Figure 1 below). The Academy Director and Deputy Director catalyze the growth and professional development of the Scholars in collaboration with their Career Guides, assess the progress of the Scholars, and facilitate communication and collaboration among all Academy members. The Career Guide is not required to be at the same institution as the Scholar; however, if the (primary) Career Guide is from a different institution, a secondary Career Guide at the Scholar’s institution is needed. The NFRA will give Scholars opportunities to operate in a collegial, highly dynamic, and cutting-edge center to lead neurofibromatosis research to a new frontier. The NFRA will provide a platform for Scholars to collaborate with leaders in the neurofibromatosis field and advance research for neurofibromatosis patients. The NFRA leadership team will also provide opportunities to NFRP FY23 (and subsequent year awardees) Early Investigator Research Award and NFRP FY23 (and subsequent year awardees) New Investigator Award – Early-Stage Investigator researchers to engage with NFRP NFRA Scholars. This FY23 funding opportunity is soliciting applications for an Academy Director and Deputy Director to lead the NFRA. The Academy Director and Deputy Director (referred to as Academy Leadership) must be established neurofibromatosis researchers and can be at different institutions. The Academy Leadership must demonstrate a strong record of mentoring and training early-career independent investigators, a commitment to leadership, the ability to articulate methods toward research collaborations, and the ability to objectively assess the progress of all Scholars in the NFRA. Early-career independent investigators interested in applying to become a member of the NFRA should refer to the FY23 NFRP Neurofibromatosis Research Academy – Scholar Award program announcement (HT9425-23-NFRP-NFRA-SA). Note: An invited oral presentation is a requirement for application review of the NFRP NFRA-LA, as described in Section II.D.2.b, Full Application Submission Content. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Pre-Application Submission Deadline and Application Submission Deadline have been extended. Please see Program Announcement in "Attachments" tab for a revised document with updated submission dates. | Aug 10, 2023 | |
May 22, 2023 |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | HT9425-23-NFRP-NFRA-LA |
Funding Opportunity Title: | DoD Neurofibromatosis Research Academy-Leadership Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 1 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | May 22, 2023 |
Last Updated Date: | Aug 10, 2023 |
Original Closing Date for Applications: | Aug 25, 2023 |
Current Closing Date for Applications: | Oct 05, 2023 |
Archive Date: | Nov 04, 2023 |
Estimated Total Program Funding: | $2,080,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: |
All applications for this award must address at least the strategic goal “Increase research capacity” as stated in Section II.A.1 above. The NFRP Neurofibromatosis Research Academy (NFRA) will bring together established investigators (Director and Deputy Director) and early-career independent investigators (Scholars) to develop successful, highly productive neurofibromatosis researchers that will conduct research with the aim of lessening the clinical impact of NF1, NF2, and Schwannomatosis. The NFRA is a unique, multi-institutional interactive virtual research academy focused on supporting innovative high-impact research in a collaborative research and career development environment. The NFRA will provide a framework of intensive monitoring and iterative guidance with proposed research, national networking, collaborations, and a peer group for Scholars. The NFRA is a platform that consists of Scholars and their Career Guides (mentors) from different institutions, and an Academy Director and Deputy Director (see Figure 1 below). The Academy Director and Deputy Director catalyze the growth and professional development of the Scholars in collaboration with their Career Guides, assess the progress of the Scholars, and facilitate communication and collaboration among all Academy members. The Career Guide is not required to be at the same institution as the Scholar; however, if the (primary) Career Guide is from a different institution, a secondary Career Guide at the Scholar’s institution is needed. The NFRA will give Scholars opportunities to operate in a collegial, highly dynamic, and cutting-edge center to lead neurofibromatosis research to a new frontier. The NFRA will provide a platform for Scholars to collaborate with leaders in the neurofibromatosis field and advance research for neurofibromatosis patients. The NFRA leadership team will also provide opportunities to NFRP FY23 (and subsequent year awardees) Early Investigator Research Award and NFRP FY23 (and subsequent year awardees) New Investigator Award – Early-Stage Investigator researchers to engage with NFRP NFRA Scholars. This FY23 funding opportunity is soliciting applications for an Academy Director and Deputy Director to lead the NFRA. The Academy Director and Deputy Director (referred to as Academy Leadership) must be established neurofibromatosis researchers and can be at different institutions. The Academy Leadership must demonstrate a strong record of mentoring and training early-career independent investigators, a commitment to leadership, the ability to articulate methods toward research collaborations, and the ability to objectively assess the progress of all Scholars in the NFRA. Early-career independent investigators interested in applying to become a member of the NFRA should refer to the FY23 NFRP Neurofibromatosis Research Academy – Scholar Award program announcement (HT9425-23-NFRP-NFRA-SA). Note: An invited oral presentation is a requirement for application review of the NFRP NFRA-LA, as described in Section II.D.2.b, Full Application Submission Content. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | HT9425-23-NFRP-NFRA-LA |
Funding Opportunity Title: | DoD Neurofibromatosis Research Academy-Leadership Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 1 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | May 22, 2023 |
Last Updated Date: | May 22, 2023 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Aug 25, 2023 |
Archive Date: | Sep 24, 2023 |
Estimated Total Program Funding: | $2,080,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: |
All applications for this award must address at least the strategic goal “Increase research capacity” as stated in Section II.A.1 above. The NFRP Neurofibromatosis Research Academy (NFRA) will bring together established investigators (Director and Deputy Director) and early-career independent investigators (Scholars) to develop successful, highly productive neurofibromatosis researchers that will conduct research with the aim of lessening the clinical impact of NF1, NF2, and Schwannomatosis. The NFRA is a unique, multi-institutional interactive virtual research academy focused on supporting innovative high-impact research in a collaborative research and career development environment. The NFRA will provide a framework of intensive monitoring and iterative guidance with proposed research, national networking, collaborations, and a peer group for Scholars. The NFRA is a platform that consists of Scholars and their Career Guides (mentors) from different institutions, and an Academy Director and Deputy Director (see Figure 1 below). The Academy Director and Deputy Director catalyze the growth and professional development of the Scholars in collaboration with their Career Guides, assess the progress of the Scholars, and facilitate communication and collaboration among all Academy members. The Career Guide is not required to be at the same institution as the Scholar; however, if the (primary) Career Guide is from a different institution, a secondary Career Guide at the Scholar’s institution is needed. The NFRA will give Scholars opportunities to operate in a collegial, highly dynamic, and cutting-edge center to lead neurofibromatosis research to a new frontier. The NFRA will provide a platform for Scholars to collaborate with leaders in the neurofibromatosis field and advance research for neurofibromatosis patients. The NFRA leadership team will also provide opportunities to NFRP FY23 (and subsequent year awardees) Early Investigator Research Award and NFRP FY23 (and subsequent year awardees) New Investigator Award – Early-Stage Investigator researchers to engage with NFRP NFRA Scholars. This FY23 funding opportunity is soliciting applications for an Academy Director and Deputy Director to lead the NFRA. The Academy Director and Deputy Director (referred to as Academy Leadership) must be established neurofibromatosis researchers and can be at different institutions. The Academy Leadership must demonstrate a strong record of mentoring and training early-career independent investigators, a commitment to leadership, the ability to articulate methods toward research collaborations, and the ability to objectively assess the progress of all Scholars in the NFRA. Early-career independent investigators interested in applying to become a member of the NFRA should refer to the FY23 NFRP Neurofibromatosis Research Academy – Scholar Award program announcement (HT9425-23-NFRP-NFRA-SA). Note: An invited oral presentation is a requirement for application review of the NFRP NFRA-LA, as described in Section II.D.2.b, Full Application Submission Content. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Related Documents
Packages
Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
12.420 | PKG00281807 | May 22, 2023 | Oct 05, 2023 | View |